Related Experiment Video
Updated: Jul 2, 2025

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy
Zhuang Zhu1, Shaoming Li1, Xiaopeng Yin2
1Department of Oral and Maxillofacial Reconstruction, the Affiliated Hospital of Qingdao University, Qingdao 266555, China; School of Stomatology, Qingdao University, Qingdao 266003, China; Department of Oral and Maxillofacial Surgery, the Affiliated Hospital of Qingdao University, Qingdao 266555, China.
Abstract:
The DNA damage response (DDR) safeguards the stable genetic information inheritance by orchestrating a complex protein network in response to DNA damage. However, this mechanism can often hamper the effectiveness of radiotherapy and DNA-damaging chemotherapy in destroying tumor cells, causing cancer resistance. Inhibiting DDR can significantly improve tumor cell sensitivity to radiotherapy and DNA-damaging chemotherapy. Thus, DDR can be a potential target for cancer treatment. Post-translational modifications (PTMs) of DDR-associated proteins profoundly affect their activity and function by covalently attaching new functional groups. O-GlcNAcylation (O-linked-N-acetylglucosaminylation) is an emerging PTM associated with adding and removing O-linked N-acetylglucosamine to serine and threonine residues of proteins. It acts as a dual sensor for nutrients and stress in the cell and is sensitive to DNA damage. However, the explanation behind the specific role of O-GlcNAcylation in the DDR remains remains to be elucidated. To illustrate the complex relationship between O-GlcNAcylation and DDR, this review systematically describes the role of O-GlcNAcylation in DNA repair, cell cycle, and chromatin. We also discuss the defects of current strategies for targeting O-GlcNAcylation-regulated DDR in cancer therapy and suggest potential directions to address them.
Insights
Targeting the DNA damage response (DDR) pathway is crucial for cancer therapy. This review explores how O-GlcNAcylation, a key post-translational modification, influences DDR and impacts cancer treatment effectiveness.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- The DNA damage response (DDR) is vital for maintaining genomic stability but can lead to cancer treatment resistance.
- Post-translational modifications (PTMs), including O-GlcNAcylation, regulate DDR protein activity.
- O-GlcNAcylation is sensitive to cellular stress and nutrient status, suggesting a role in DDR.
Purpose of the Study:
- To elucidate the intricate role of O-GlcNAcylation in the DNA damage response (DDR).
- To review the impact of O-GlcNAcylation on DNA repair, cell cycle progression, and chromatin regulation.
- To discuss current therapeutic strategies targeting O-GlcNAcylation in cancer and propose future directions.
Main Methods:
- Systematic review of existing literature on O-GlcNAcylation and DDR.
- Analysis of the interplay between O-GlcNAcylation and key DDR pathways.
- Discussion of therapeutic implications and challenges.
Main Results:
- O-GlcNAcylation significantly modulates the function of DDR proteins.
- This modification influences DNA repair efficiency, cell cycle checkpoints, and chromatin accessibility.
- Dysregulation of O-GlcNAcylation can impact cancer cell sensitivity to genotoxic therapies.
Conclusions:
- O-GlcNAcylation is a critical regulator of the DNA damage response.
- Targeting O-GlcNAcylation presents a promising, yet complex, strategy for enhancing cancer therapy.
- Further research is needed to fully understand and exploit O-GlcNAcylation-mediated DDR modulation for clinical benefit.
More Related Videos
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
10:12Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Base Excision Repair
The first step of...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...